Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy.

Abstract

OBJECTIVES:

Gastrointestinal dysfunction is a common complication in familial amyloidotic polyneuropathy, and gastrointestinal symptoms are associated with a patient's nutritional status. The object of this study was to evaluate changes in peritransplant gastrointestinal symptoms and the nutritional status of familial amyloidotic polyneuropathy patients using the modified body mass index following a living-donor liver transplant.

MATERIALS AND METHODS:

In a retrospective analysis, we compared 17 Japanese familial amyloidotic polyneuropathy patients who underwent living-donor liver transplant in Kumamoto University Hospital between 2000 and 2009 with a control group of 28 patients with chronic liver disease. We analyzed the peritransplant gastrointestinal symptoms, nutritional status, duration of central venous catheterization, and postoperative hospital stay. The Mann-Whitney U test and Fisher exact test were used to analyze relations between the familial amyloidotic polyneuropathy group and control group, and the Wilcoxon signed-rank test, to analyze the relation of perioperative modified body mass index, with a value for P < .05 considered statistically significant.

RESULTS:

The duration of central venous catheterization and postoperative hospital stay were significantly longer in the familial amyloidotic polyneuropathy group than they were in the control group. There was no significant difference between modified body mass index preoperatively and 1 year after living-donor liver transplant. Although gastrointestinal symptoms were typically mild before living-donor liver transplant, the familial amyloidotic polyneuropathy group experienced a temporary deterioration in gastrointestinal symptoms after receiving the living-donor liver transplant but recovered after approximately 2 months.

CONCLUSIONS:

Although familial amyloidotic polyneuropathy patients experienced temporary exacerbations of gastrointestinal symptoms, their nutritional status was not affected during the peritransplant period, and they generally recovered within 2 months.

• Authors: Yuki Ohya, Kaori Isono, Konen Obayashi, Shintaro Hayashida, Kwang-Jong Lee, Hidekazu Yamamoto, Takayuki Takeichi, Katsuhiro Asonuma, Yukio Ando, Yukihiro Inomata
• Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation (Exp Clin Transplant) Vol. 11 Issue 4 Pg. 327-31 (Aug 2013) ISSN: 2146-8427 [Electronic] Turkey
• PMID: 23432183 (Publication Type: Journal Article)

Topics

• Adult
• Amyloid Neuropathies, Familial (complications, diagnosis, physiopathology, surgery)
• Body Mass Index
• Catheterization, Central Venous
• Female
• Gastrointestinal Diseases (diagnosis, etiology, physiopathology)
• Hospitals, University
• Humans
• Japan
• Length of Stay
• Liver Transplantation (adverse effects, methods)
• Living Donors
• Male
• Middle Aged
• Nutritional Status
• Nutritional Support
• Recovery of Function
• Retrospective Studies
• Time Factors
• Treatment Outcome